Kay Hagan Tick Reauthorization Act
- Bill Number
- S. 2294
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-07-15: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4370-4371)
- Last Updated
- 2025-09-08T20:37:06Z
AI-Generated Summary
Summary of S. 2294: Kay Hagan Tick Reauthorization Act
Purpose
This legislation reauthorizes federal programs focused on preventing and addressing tick-borne diseases, including the development of a national strategy and support for health departments in managing vector-borne illnesses. It extends these efforts through fiscal year 2030 with updated funding levels.
Key Provisions
- National Strategy and Regional Centers: Amends the Public Health Service Act to require consultation with appropriate individuals (rather than a specific working group) when developing strategies for vector-borne diseases. It also sets funding at $8,000,000 annually for fiscal years 2026 through 2030.
- Support for Health Departments: Updates funding for enhanced assistance to health departments addressing vector-borne diseases to $19,000,000 annually for fiscal years 2026 through 2030.
Significant Changes to Existing Law
- Reduces annual funding for the national strategy program from $10,000,000 (fiscal years 2021–2025) to $8,000,000 (fiscal years 2026–2030).
- Reduces annual funding for health department support from $20,000,000 (fiscal years 2021–2025) to $19,000,000 (fiscal years 2026–2030).
- Removes the explicit requirement to consult the Tick-Borne Disease Working Group established under the 21st Century Cures Act, broadening input to general appropriate individuals.
Potential Impacts
- Government Agencies: Provides continued but modestly reduced funding to the Department of Health and Human Services and Centers for Disease Control and Prevention for tick-borne disease initiatives, potentially affecting program scale through 2030.
- Citizens: Supports ongoing public health efforts to combat diseases like Lyme disease, benefiting individuals in affected regions by maintaining research, prevention, and response activities.
- International Relations: No direct impacts identified.
Main Stakeholders Affected
- Federal agencies such as the Department of Health and Human Services and state/local health departments responsible for vector-borne disease management.
- Researchers, medical professionals, and advocacy groups focused on tick-borne illnesses.
- Individuals and communities at risk from tick-borne diseases.
Notable Legal, Constitutional, or Political Implications
- This is a routine reauthorization bill with no apparent constitutional challenges, as it operates within existing public health authorities under the Public Health Service Act.
- The changes maintain federal support for disease prevention without introducing new regulatory mandates or altering state-federal relationships.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (5)
Sen. Smith, Tina [D-MN], Sen. King, Angus S., Jr. [I-ME], Sen. Hawley, Josh [R-MO], Sen. Klobuchar, Amy [D-MN], Sen. Gillibrand, Kirsten E. [D-NY]
Recent Actions
- 2025-07-15: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4370-4371)
- 2025-07-15: Introduced in Senate
Bill Versions
- Kay Hagan Tick Reauthorization Act — issued 2025-07-15 — PDF (2 pages)